出生前DNAシーケンスの世界市場レポート 2025年

出生前DNAシーケンス市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR16.8％で53億米ドルに成長します。予測期間の成長は、早期発見に対する消費者の需要、妊産婦の年齢上昇と妊娠リスク、公衆衛生への取り組み、規制当局の支援とガイドライン、データ分析の進歩に起因します。予測期間の主な動向には、研究開発への取り組み、倫理的および規制上の配慮、データ解釈ツールの改善、精密医療の統合、出生前遺伝カウンセリングなどが含まれます。

予想されるがん罹患率の上昇が出生前DNAシーケンス市場の成長を牽引します。制御不能な細胞増殖と拡散を特徴とするがんは、胎児の異数性を検出し、胎児のがんを特定するために出生前DNAシーケンスの使用を促します。このシークエンシング法は、人のがん感受性に影響する遺伝性または生殖細胞系列のDNA変化を明らかにします。例えば、2023年1月のアメリカがん協会のデータでは、がん罹患数は2021年の1,898,160人から2023年には1,958,310人と3.16％増加しています。その結果、がんの有病率は出生前DNAシーケンス市場の原動力となっています。

出生率の増加は、今後数年間の出生前DNAシーケンス市場の成長を促進すると予測されます。出生率とは、定義された期間における特定集団の1,000人当たりの出生数を指し、通常は毎年報告されます。出生前DNAシーケンスは、胎児の遺伝子異常の検出に役立っており、選択的介入を通じて、出産時に十分な情報に基づいた生殖の選択を容易にしています。例えば、2023年1月、米国を拠点とする全国的な公衆衛生機関である疾病対策予防センターの報告によると、米国では登録出生数が前年比1％増の3,664,292人となった。その結果、出生率の増加が出生前DNAシーケンス市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界出生前DNAシーケンス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の出生前DNAシーケンス市場：成長率分析
• 世界の出生前DNAシーケンス市場の実績：規模と成長, 2019-2024
• 世界の出生前DNAシーケンス市場の予測：規模と成長, 2024-2029, 2034F
• 世界出生前DNAシーケンス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の出生前DNAシーケンス市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝性疾患
• 非遺伝性疾患
• 世界の出生前DNAシーケンス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血友病
• ダウン症候群
• 嚢胞性線維症
• 自閉症
• ディジョルグル症候群
• エイズ（後天性免疫不全症候群）
• がん
• その他の用途
• 世界の出生前DNAシーケンス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 学術調査
• 臨床調査
• 病院と診療所
• 製薬およびバイオテクノロジー企業
• その他のエンドユーザー
• 世界の出生前DNAシーケンス市場、遺伝性疾患のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単一遺伝子疾患
• 染色体異常
• 世界の出生前DNAシーケンス市場、非遺伝性疾患の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 母親の健康状態

第7章 地域別・国別分析

• 世界の出生前DNAシーケンス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の出生前DNAシーケンス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 出生前DNAシーケンス市場：競合情勢
• 出生前DNAシーケンス市場：企業プロファイル
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • BGI Group Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Natera Inc.
• Myriad Genetics Inc.
• Invitae Corporation
• PerkinElmer Inc.
• Macrogen Inc.
• Pacific Biosciences of California Inc.
• Genewiz LLC
• 10x Genomics Inc.
• Oxford Nanopore Technologies Limited
• Thermo Fisher Scientific Inc.
• Berry Genomics Co. Ltd.
• Centrillion Technology Holdings Corp.
• Cynvenio Biosystems Inc.
• Eurofins LifeCodexx AG
• GeneDx Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 出生前DNAシーケンス市場2029：新たな機会を提供する国
• 出生前DNAシーケンス市場2029：新たな機会を提供するセグメント
• 出生前DNAシーケンス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Prenatal DNA sequencing is a method employed to sequence the DNA of an unborn baby, utilizing a blood sample from the mother to unveil the complete genetic code of the fetus. This technique is instrumental in detecting fetal disorders or diseases.

The primary types of prenatal DNA sequencing encompass genetic diseases and nonhereditary diseases. Genetic diseases refer to disorders or diseases caused by mutations in one or more genes. DNA sequencing plays a crucial role in determining whether a gene carries a mutation leading to a specific disorder. Applications of prenatal DNA sequencing include conditions such as hemophilia, Down syndrome, cystic fibrosis, autism, DiGeorge syndrome, AIDS, cancer, and others. Various users, including academic research, clinical research, hospitals and clinics, as well as pharmaceutical and biotechnology companies, employ this technology.

The prenatal DNA sequencing market research report is one of a series of new reports from The Business Research Company that provides prenatal DNA sequencing market statistics, including the prenatal DNA sequencing industry global market size, regional shares, competitors with a prenatal DNA sequencing market share, detailed prenatal DNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal DNA sequencing industry. This prenatal DNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal DNA sequencing market size has grown rapidly in recent years. It will grow from $2.5 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to changing patient preferences, medical advancements and research, non-invasive testing adoption, rising maternal age, improved accuracy and reliability.

The prenatal DNA sequencing market size is expected to see rapid growth in the next few years. It will grow to $5.3 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to consumer demand for early detection, rising maternal age and pregnancy risks, public health initiatives, regulatory support and guidelines, advancements in data analysis. Major trends in the forecast period include research and development efforts, ethical and regulatory considerations, improved data interpretation tools, precision medicine integration, prenatal genetic counseling.

The anticipated rise in cancer prevalence is set to drive the growth of the prenatal DNA sequencing market. Cancer, characterized by uncontrolled cell growth and spread, prompts the use of prenatal DNA sequencing to detect fetal aneuploidy and identify cancer in the fetus. This sequencing method unveils inherited or germline DNA changes influencing a person's cancer susceptibility. For example, data from the American Cancer Society in January 2023 showed an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth rate of 3.16%. Consequently, the prevalence of cancer acts as a driving force for the prenatal DNA sequencing market.

The increasing birth rate is anticipated to drive the growth of the prenatal DNA sequencing market in the coming years. The birth rate refers to the number of live births per 1,000 individuals in a specific population over a defined period, typically reported annually. Prenatal DNA sequencing is instrumental in detecting genetic abnormalities in unborn fetuses, facilitating informed reproductive choices during childbirth through selective interventions. For example, in January 2023, a report from the Centers for Disease Control and Prevention, a U.S.-based national public health organization, indicated that the United States experienced a 1% rise in registered births, amounting to 3,664,292, compared to the previous year. Consequently, the increasing birth rate is propelling the prenatal DNA sequencing market.

Product innovation is a prominent trend in the prenatal DNA sequencing market, with major companies concentrating on developing innovative solutions to enhance their market standing. Juno Diagnostics, Inc., a U.S.-based health technology company, introduced the noninvasive prenatal screening test 'Hazel' in November 2022. Designed with no risk of miscarriage, the test can be performed as early as 9 weeks into pregnancy using a small blood sample. It screens for common genetic conditions such as Down syndrome, Edwards syndrome, and Patau syndrome.

Major companies in the prenatal DNA sequencing market are pursuing a strategic partnership approach to improve technology integration and broaden their market presence. A strategic partnership generally involves a collaborative relationship among two or more organizations that combine their resources, expertise, and efforts to achieve shared goals or objectives. For example, in December 2023, BillionToOne, a U.S.-based precision diagnostics company, teamed up with a Johnson & Johnson subsidiary, a U.S.-based pharmaceutical firm, for the AZALEA Phase 3 clinical trial of nipocalimab. This trial focuses on pregnancies at risk for severe hemolytic disease of the fetus and newborn (HDFN). BillionToOne will supply its UNITY Fetal Antigen Non-invasive Prenatal Test (UNITY Fetal Antigen CTA) to screen and determine participant eligibility. HDFN is a rare condition resulting from blood type incompatibility between the pregnant individual and the fetus, which can lead to life-threatening anemia.

In November 2022, Myriad Genetics, Inc., a U.S.-based provider of genetic testing and precision medicine, acquired Gateway Genomics, LLC, a personal genomics and prenatal DNA company. The undisclosed acquisition is expected to enhance Myriad's women's health product portfolio and provide access to personalized genetic tests, strengthening its position in the market.

Major companies operating in the prenatal DNA sequencing market include Agilent Technologies Inc., BGI Group, F. Hoffmann-La Roche Ltd, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Myriad Genetics Inc., Invitae Corporation, PerkinElmer Inc., Macrogen Inc., Pacific Biosciences of California Inc., Genewiz LLC, 10x Genomics Inc., Oxford Nanopore Technologies Limited, Thermo Fisher Scientific Inc., Berry Genomics Co. Ltd., Centrillion Technology Holdings Corp., Cynvenio Biosystems Inc., Eurofins LifeCodexx AG, GeneDx Inc., Genoma SA, Helix OpCo LLC, Igenomix S.L., Integrated DNA Technologies Inc.

North America was the largest region in the prenatal DNA sequencing market in 2024. The regions covered in the prenatal dna sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal dna sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prenatal DNA sequencing market includes revenues earned by entities by provide services such as prenatal next-generation sequencing, whole genome sequencing, DNA extraction, DNA fragmentation, and data collection and sequence analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal DNA Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal dna sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal dna sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prenatal dna sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Genetic Diseases; Nonhereditary Diseases
• 2) By Application: Hemophilia; Down Syndrome; Cystic Fibrosis; Autism; DiGeorge Syndrome; AIDS (Acquired Immunodeficiency Syndrome); Cancer; Other Applications
• 3) By End User: Academic Research; Clinical Research; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
• Subsegments:
• 1) By Genetic Diseases: Monogenic Disorders; Chromosomal Abnormalities
• 2) By Nonhereditary Diseases: Infectious Diseases; Maternal Health Conditions
• Companies Mentioned: Agilent Technologies Inc.; BGI Group; F. Hoffmann-La Roche Ltd; Illumina Inc.; Laboratory Corporation of America Holdings
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prenatal DNA Sequencing Market Characteristics

3. Prenatal DNA Sequencing Market Trends And Strategies

4. Prenatal DNA Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Prenatal DNA Sequencing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Prenatal DNA Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Prenatal DNA Sequencing Market Growth Rate Analysis
• 5.4. Global Prenatal DNA Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Prenatal DNA Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Prenatal DNA Sequencing Total Addressable Market (TAM)

6. Prenatal DNA Sequencing Market Segmentation

• 6.1. Global Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Diseases
• Nonhereditary Diseases
• 6.2. Global Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hemophilia
• Down Syndrome
• Cystic Fibrosis
• Autism
• DiGeorgre Syndrome
• AIDS (Acquired Immunodeficiency Syndrome)
• Cancer
• Other Applications
• 6.3. Global Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic Research
• Clinical Research
• Hospitals And Clinics
• Pharmaceutical And Biotechnology Companies
• Other End Users
• 6.4. Global Prenatal DNA Sequencing Market, Sub-Segmentation Of Genetic Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monogenic Disorders
• Chromosomal Abnormalities
• 6.5. Global Prenatal DNA Sequencing Market, Sub-Segmentation Of Nonhereditary Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Maternal Health Conditions

7. Prenatal DNA Sequencing Market Regional And Country Analysis

• 7.1. Global Prenatal DNA Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Prenatal DNA Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prenatal DNA Sequencing Market

• 8.1. Asia-Pacific Prenatal DNA Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prenatal DNA Sequencing Market

• 9.1. China Prenatal DNA Sequencing Market Overview
• 9.2. China Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prenatal DNA Sequencing Market

• 10.1. India Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prenatal DNA Sequencing Market

• 11.1. Japan Prenatal DNA Sequencing Market Overview
• 11.2. Japan Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prenatal DNA Sequencing Market

• 12.1. Australia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prenatal DNA Sequencing Market

• 13.1. Indonesia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prenatal DNA Sequencing Market

• 14.1. South Korea Prenatal DNA Sequencing Market Overview
• 14.2. South Korea Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prenatal DNA Sequencing Market

• 15.1. Western Europe Prenatal DNA Sequencing Market Overview
• 15.2. Western Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prenatal DNA Sequencing Market

• 16.1. UK Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prenatal DNA Sequencing Market

• 17.1. Germany Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prenatal DNA Sequencing Market

• 18.1. France Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prenatal DNA Sequencing Market

• 19.1. Italy Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prenatal DNA Sequencing Market

• 20.1. Spain Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prenatal DNA Sequencing Market

• 21.1. Eastern Europe Prenatal DNA Sequencing Market Overview
• 21.2. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prenatal DNA Sequencing Market

• 22.1. Russia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prenatal DNA Sequencing Market

• 23.1. North America Prenatal DNA Sequencing Market Overview
• 23.2. North America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prenatal DNA Sequencing Market

• 24.1. USA Prenatal DNA Sequencing Market Overview
• 24.2. USA Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prenatal DNA Sequencing Market

• 25.1. Canada Prenatal DNA Sequencing Market Overview
• 25.2. Canada Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prenatal DNA Sequencing Market

• 26.1. South America Prenatal DNA Sequencing Market Overview
• 26.2. South America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prenatal DNA Sequencing Market

• 27.1. Brazil Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prenatal DNA Sequencing Market

• 28.1. Middle East Prenatal DNA Sequencing Market Overview
• 28.2. Middle East Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prenatal DNA Sequencing Market

• 29.1. Africa Prenatal DNA Sequencing Market Overview
• 29.2. Africa Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prenatal DNA Sequencing Market Competitive Landscape And Company Profiles

• 30.1. Prenatal DNA Sequencing Market Competitive Landscape
• 30.2. Prenatal DNA Sequencing Market Company Profiles
  • 30.2.1. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. BGI Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

31. Prenatal DNA Sequencing Market Other Major And Innovative Companies

• 31.1. Natera Inc.
• 31.2. Myriad Genetics Inc.
• 31.3. Invitae Corporation
• 31.4. PerkinElmer Inc.
• 31.5. Macrogen Inc.
• 31.6. Pacific Biosciences of California Inc.
• 31.7. Genewiz LLC
• 31.8. 10x Genomics Inc.
• 31.9. Oxford Nanopore Technologies Limited
• 31.10. Thermo Fisher Scientific Inc.
• 31.11. Berry Genomics Co. Ltd.
• 31.12. Centrillion Technology Holdings Corp.
• 31.13. Cynvenio Biosystems Inc.
• 31.14. Eurofins LifeCodexx AG
• 31.15. GeneDx Inc.

32. Global Prenatal DNA Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal DNA Sequencing Market

34. Recent Developments In The Prenatal DNA Sequencing Market

35. Prenatal DNA Sequencing Market High Potential Countries, Segments and Strategies

• 35.1 Prenatal DNA Sequencing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Prenatal DNA Sequencing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Prenatal DNA Sequencing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer